NEW YORK (GenomeWeb News) – Rosetta Genomics today said that its distribution agreement with GeneKor Medical has been expanded to include Romania and Turkey.
GeneKor now has the exclusive sales and marketing rights to Rosetta Genomics' microRNA-based cancer testing services in Romania, and non-exclusive rights in Turkey. The companies originally inked a distribution deal covering Greece in 2010.
Financial and other terms of today's deal were not disclosed.
GeneKor is a molecular diagnostic service provider headquartered in Athens, Greece.
"This extension to our agreement with GeneKor will enhance patient access to our microRNA-based testing services in Turkey and Romania, and will potentially result in more personalized treatment approaches for many patients," E. Robert Wassman, chief medical officer of Rosetta Genomics, said in a statement.